• A breath of unique innovation

    Pioneering inhalation products and extensive know-how in drug formulation

    Get to know us!
  • A formulation to match the device

    The right chemistry in the right inhaler takes you to the market faster

    Take me there!
  • Capitalize on a pool of knowledge

    Get from bench to bedside – faster and at lower risk

    Discover how
  • For those who need it the most

    ICOone™ – inhale vaccine instead of injecting. Safe method that eliminates all cold-chain storage.

    Learn how
  • A breath of unique innovation »
  • A formulation to match the device »
  • Capitalize on a pool of knowledge »
  • For those who need it the most »

News

  • Iconovo at Investor Meeting in Copenhagen

    2018-11-05
    Biotech Invites to Quarterly Conference - This time to Q4. Tuesday, 27 November 2018 in Copenhagen. Come and meet five ... Read more
  • Iconovo develops new formulations to strengthen the product portfolio (only in Swedish)

    2018-11-02
    Breddat erbjudande med egen utveckling. Iconovo AB (publ) utökar erbjudandet med egenutvecklade läkemedelsformulering... Read more
  • Iconovo at CPhI in Madrid

    2018-10-17
    Iconovo attended CPhI in Madrid last week which marked the start of our new collaboration with Stevanato Group and ICOca... Read more
  • ICONOVO SIGNS AGREEMENT FOR DEVELOPMENT OF VACCINE AGAINST TUBERCULOSIS

    2018-10-15
    Iconovo signs an agreement with McMaster University for development of vaccine against tuberculosis The innovative Swed... Read more
  • Interview with Dr Orest Lastow September 2018 (only in Swedish)

    2018-09-24
    Skånebolaget Iconovo utvecklar inhalatorer med tillhörande läkemedelsberedning som främst används för att behandla... Read more
  • MIKAEL EKSTRÖM NEW VP DEVELOPMENT AT ICONOVO

    2018-08-30
    Dr. Mikael Ekström has joined Iconovo as Vice President Development Mikael has nearly 30 years of experience in inhala... Read more
  • Market analys of Iconovo by Erik Penser Bank (only in Swedish)

    2018-08-13
    En välsignelse från Italien Under kvartalet fakturerade bolaget SEKm 5,5 (7,7), vilket var under vår förväntan o... Read more
  • Iconovo signs an agreement with Stevanato Group regarding the manufacture, sale and distribution of ICOcap

    2018-07-03
    The inhalation developer Iconovo AB (publ) announced today that the company has signed an agreement with the multination... Read more
  • Dr Orest Lastow is lecturing at Dry Powder Inhalers Annual Conference London 20-21 June 2018

    2018-05-25
    The second generation of DPIs have become either established on the market or are a significant way along the approval ... Read more
  • Interview with Dr Orest Lastow May 2018 (only in Swedish)

    2018-05-24
    På Erik Penser Banks bolagsdag den 23 maj fick Finwire.tv möjligheten att intervjua Dr Orest Lastow, VD på Iconovo. S... Read more
Older news

A unique platform of inhalation devices

Iconovo offers a full range of innovative, ready-to-use inhalation devices for dry powder inhalation (DPI). Our solution consists of a combination of inhaler and the exactly right formulation to match the device and the drug to be delivered. Each solution is based on our proprietary platform but will be customized and adapted to your unique requirements. We can also provide performance testing, full documentation and a complete supply chain. Our long and unique experience and capability in the development of inhalation devices and formulations enable you to get your product to the market in a fast and efficient way.